Research

Yiwei CHU

Published time 2021-09-03 10:38Click 196times
Dr. Chu received her M.D in Shanghai Medical University, and her PhD in Immunology in Fudan University in China. She was a visiting scholar in University of Washington, Seattle, USA from 1995-1998, and a visiting professor in Earle A Chiles Research Institute, Portland, Oregon, USA in 2003-2004. Dr. Chu started her carrier in China where she distinguished herself through her work on tumor immunology. Her research interesting has two major focuses. The first is tumor immunology and Immunotherapy, followed by a series of successful projects focusing on tumor vaccine for glioma patients and CAR-T designing for solid tumors. The second is to investigate the regulatory functional of B lymphocyte both in autoimmune disease and cancer, which is the emerging field in Immunology. She published 251 scientific papers, which some of them are in top with high impact factors (H-Index 45 with 6830 citations). 

Dr.Chu is a supervisory scientists and team leader, she has served in many professional organizations, including IUIS (International Union of Immunology Society) General Assembly Representative, 17th /18thICI (IUIS 2019/2022) scientific program committee member, vice president of both CSI(Chinese Society for Immunology), and SCI(Shanghai Society for Immunology). She is the chairman of Committee for Woman Scientists in CSI. She leads more than 7,000 women membership for academic and teaching in annual meeting and various activities.


EMAIL:Yiwei_chu@126.com